Neuroendocrine tumors future or investigational therapies

Revision as of 19:59, 30 August 2012 by Raviteja Reddy Guddeti (talk | contribs) (Created page with "__NOTOC__ {{Neuroendocrine tumors}} {{CMG}} == Overview == ==Future or Investigational Therapies== Therapies based on growth factor inhibitors are in the experimental stage....")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Neuroendocrine tumors Microchapters

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk factors

Natural History, Complications and Prognosis

History and Symptoms

Laboratory Findings

CT scan

PET scan

Medical Therapy

Surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Future or Investigational Therapies

Therapies based on growth factor inhibitors are in the experimental stage. These inhibitors of epidermal growth factor receptors (EGFRs), of vascular endothelial growth factor receptors (VEGFRs), and of angiopoietin-related growth factor (AGF) include imatinib, sunitinib, temozolide, thalidomide, sorafenib, and panitumumab.

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Neuroendocrine_tumors_future_or_investigational_therapies&oldid=705163"